Macau Casino Gambli...
Health Care: Health Services
Antares Pharma Inc. (AIS: AMEX)
$2.76 0.04 | 1.47%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 0.61 | 0.77 | 0.98 |
| Price to Sales (TTM) | 14.57 | 1.97 | 1.42 |
| Price to Book (MRQ) | 8.97 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 9.59 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | -99.00 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -120.00 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 92.30 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 28.40 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 21.87 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 10.18 | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.00 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 4.40 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.34 | 0.96 |
| Interest Coverage (TTM) | n.a. | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 63.70 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 67.60 | 59.90 | 47.70 |
| EBITD Margin (TTM) | -14.00 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | -114.97 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -15.60 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -82.30 | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.16 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -82.30 | 8.70 | 7.00 |
| Return on Assets (TTM) | -7.60 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | -33.30 | 5.20 | 2.50 |
| Return on Investment (TTM) | -9.60 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | -53.70 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 681,155.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | -106,265.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 13.10 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 8.70 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 0.70 | 0.60 | 0.40 |
Portfolios with AIS
- Portfolio NameUser Type
- Contributor5 Stocks Under-$10 Setting ...
- UserSMITTY
- Contributor8 Health Care Stocks With R...
- ContributorBreakout Stocks Of The Week...
- UserCurrent
- Userparvardigar
- Userhpats Portfolio 1
- Contributor11 Penny Stocks to Sell Now
- Userphospho
- UserTraderO4000 Portfolio 1
Latest AIS Headlines from TheStreet
- Antares Stock Hits New 52-Week High (AIS) 03.20.12 | 11:03 am
- Antares Pharma Inc. Stock Upgraded (AIS) 03.14.12 | 05:03 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Antares Stock Gaps Down On Today's Open (AIS) 12.15.11 | 09:12 am
- BioSante Pharma Readying Release of 'Female Viagra' Study Results 12.14.11 | 12:12 pm
- 5 Stocks Under $10 With Big Upside Potential 11.18.11 | 06:11 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- 4 Stocks Setting Up to Break Out 06.10.11 | 03:06 pm
- 11 Penny Stocks to Sell Now 07.20.10 | 11:07 am
- Hot Penny Stocks to Buy 06.14.10 | 11:06 am
Press Releases for AIS
- Antares Pharma To Present At The Jefferies Global Healthcare Conference - Business Wire 05.31.12 | 07:05 am
- Antares Pharma Reports First Quarter 2012 Financial And Operating Results - Business Wire 05.08.12 | 07:05 am
- Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva And Pfizer - Business Wire 04.26.12 | 09:04 am
- Antares Pharma To Present At The 11th Annual Needham Healthcare Conference - Business Wire 03.28.12 | 07:03 am
- Antares Pharma Reports Fourth Quarter And Full Year 2011 Financial And Operating Results - Business Wire 03.12.12 | 07:03 am
- Antares Pharma To Host Fourth Quarter And Full Year 2011 Earnings Call - Business Wire 03.05.12 | 07:03 am
- Antares Pharma To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 07:02 am
- Antares Pharma Appoints John J. Howarth Vice President Of Corporate Affairs - Business Wire 02.27.12 | 09:02 am
- Antares Pharma Enters Licensing Agreement With Daewoong Pharmaceuticals Co. Ltd. For Oxybutynin Gel 3% In South Korea - Business Wire 01.17.12 | 08:01 am
- Antares Pharma Enters Licensing Agreement With Pfizer Consumer Healthcare - Business Wire 12.20.11 | 09:12 am
Partner Headlines for AIS
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 05.14.12 | 09:05 am
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell - Seeking Alpha 02.22.12 | 09:02 am
- SIGA Could Be Ready For A Large Short-Term Pop - Seeking Alpha 01.15.12 | 09:01 am
- Antares Pharma's New Blockbuster Drug Has Potential To Generate Long-Term Revenue - Seeking Alpha 12.28.11 | 06:12 am
- Watson-Amgen to Develop Biosimilars - Analyst Blog - Zacks 12.20.11 | 10:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
